CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Simplifying NMR for Fluorine-containing Samples

Currently, more than 200 marketed medicines, and approximately one-third of the most successful – so called ‘blockbuster’ – drugs contain fluorine atoms in their structure. Fluorine-containing compounds span a wide variety of therapeutic classes: anti-cancer drugs, antifungal agents and NSAIDs (non-steroidal anti-inflammatory drugs), for example. Fluorine is also now commonly found in illicit and illegal drugs, including synthetic cannabinoids and psychedelic phenethylamines. Michael H. Frey and Ron Crouch from JEOL USA explain how we can use NMR to
distinguish readily between these legitimate and illegitimate substances.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026